Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2008-01-01
2008-01-01
O'Hara, Eileen (Department: 1647)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C424S143100, C424S155100, C514S002600, C514S012200
Reexamination Certificate
active
07314623
ABSTRACT:
Methods and compositions for modulating T helper (Th) cell development and function using modulators of IL-21, e.g., human IL-21, activity or level.
REFERENCES:
patent: 3710795 (1973-01-01), Higuchi et al.
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 4946778 (1990-08-01), Ladner et al.
patent: 5011912 (1991-04-01), Hopp et al.
patent: 5098833 (1992-03-01), Lasky et al.
patent: 5116964 (1992-05-01), Capon et al.
patent: 5155027 (1992-10-01), Sledziewski et al.
patent: 5216131 (1993-06-01), Lasky et al.
patent: 5225538 (1993-07-01), Capon et al.
patent: 5225539 (1993-07-01), Winter
patent: 5262564 (1993-11-01), Kun et al.
patent: 5328470 (1994-07-01), Nabel et al.
patent: 5428130 (1995-06-01), Capon et al.
patent: 5447851 (1995-09-01), Beutler et al.
patent: 5455165 (1995-10-01), Capon et al.
patent: 5514582 (1996-05-01), Capon et al.
patent: 5516964 (1996-05-01), Umansky et al.
patent: 5545806 (1996-08-01), Lonberg et al.
patent: 5545807 (1996-08-01), Surani et al.
patent: 5567584 (1996-10-01), Sledziewski et al.
patent: 5569825 (1996-10-01), Lonberg et al.
patent: 5625126 (1997-04-01), Lonberg et al.
patent: 5633425 (1997-05-01), Lonberg et al.
patent: 5661016 (1997-08-01), Lonberg et al.
patent: 5714147 (1998-02-01), Capon et al.
patent: 5750375 (1998-05-01), Sledziewski et al.
patent: 5840844 (1998-11-01), Lasky et al.
patent: 5843725 (1998-12-01), Sledziewski et al.
patent: 5916771 (1999-06-01), Hori et al.
patent: 5939598 (1999-08-01), Kucherlapati et al.
patent: 6018026 (2000-01-01), Sledziewski et al.
patent: 6057128 (2000-05-01), Donaldson et al.
patent: 6136310 (2000-10-01), Hanna et al.
patent: 6291212 (2001-09-01), Sledziewski et al.
patent: 6291646 (2001-09-01), Sledziewski et al.
patent: 6300099 (2001-10-01), Sledziewski et al.
patent: 6307024 (2001-10-01), Novak et al.
patent: 6323323 (2001-11-01), Sledziewski et al.
patent: 6406697 (2002-06-01), Capon et al.
patent: 6576744 (2003-06-01), Presnell et al.
patent: 2002/0090680 (2002-07-01), Hodge
patent: 2002/0128446 (2002-09-01), Novak et al.
patent: 2002/0137677 (2002-09-01), Sprecher et al.
patent: 2003/0108549 (2003-06-01), Carter et al.
patent: 2006/0039902 (2006-02-01), Young et al.
patent: 0 812 913 (1997-12-01), None
patent: 1 088 831 (2001-04-01), None
patent: WO 93/08829 (1993-05-01), None
patent: WO 94/02602 (1994-02-01), None
patent: WO 96/27011 (1996-09-01), None
patent: WO 96/33735 (1996-10-01), None
patent: WO 96/34096 (1996-10-01), None
patent: WO 97/20926 (1997-06-01), None
patent: WO 97/31946 (1997-09-01), None
patent: WO 97/33913 (1997-09-01), None
patent: WO 97/47741 (1997-12-01), None
patent: WO 97/47742 (1997-12-01), None
patent: WO 98/10638 (1998-03-01), None
patent: WO 98/11225 (1998-03-01), None
patent: WO 98/31811 (1998-07-01), None
patent: WO 99/47675 (1999-09-01), None
patent: WO 99/53049 (1999-10-01), None
patent: WO 00/08152 (2000-02-01), None
patent: WO 00/17235 (2000-03-01), None
patent: WO 00/27882 (2000-05-01), None
patent: WO 00/53761 (2000-09-01), None
Mijares et al. Molecular Pharmacology, vol. 58, pp. 373-379 2000.
Heany et al. Journal of Leukocyte Biology, vol. 64, pp. 135-146, Aug. 1998.
Mehta et al. Immunological Reviews, vol. 202, pp. 84-95, 2004.
James A. Wells, Sep. 18, 1990, Biochemistry, vol. 29, No. 37, pp. 8509-8517.
Brenne et al. Blood, May 2002. vol. 99, No. 10, pp. 3756-3762.
Kasaian et al. Immunity, Apr. 2002. vol. 16, pp. 559-569.
Asao et al.J. Immunol., 167:1-5 (2001).
Bazan J.F.Proc. Natl. Acad. Sci. USA, 87:6934-6938 (1990).
Bird et al.Immunity, 9(2):229-237 (1998).
Biró et al.Immunol. Lett., 46:183-187 (1995).
Brennan et al.Science, 229:81-83 (1985).
Caput et al.J. Biol. Chem., 271(28):16921-16926 (1996).
Chen et al.Proc. Natl. Acad. Sci. USA, 91:3054-3057 (1994).
Cote et al.Proc. Natl. Acad. Sci. USA, 80:2026-2030 (1983).
D'Andrea et al.Cell, 57:277-285 (1989).
Database EMBL, Accession No. AF279436 (Jul. 18, 2000).
Database EMBL, Accession No. AB049137 (Sep. 23, 2000).
Database EMBL, ID HS795114 Accession No. R52795 (May 25, 1995).
Debinski et al.J. Biol. Chem., 270(28):16775-16780 (1995).
Dusanter-Fourt et al.Medecine/Sciences, English Abstract, 10:825-835 (1994).
EMBL Database Accession No. AC002303 (Jun. 26, 1997).
Fishwild et al.Nat. Biotechnol., 14(7):845-851 (1996).
GenBank Database Accession No. M26062 (Jan. 6, 1995).
Gruber et al.J. Immunol., 152(11):5368-5374 (1994).
Hatakeyama et al.Science, 244:551-556 (1989).
Hollinger et al.Proc. Natl. Acad. Sci. USA, 90:6444-6448 (1993).
Hoogenboom et al.J. Mol. Biol., 227:381-388 (1992).
Hopp et al.Proc. Natl. Acad. Sci. USA, 78:3824-3828 (1981).
Huse et al.Science, 246:1275-1281 (1989).
Jones et al.Nature, 321:522-525 (1986).
Kaplan et al.Immunity, 4(3):313-319 (1996).
Kasaian et al.Immunity, 16(4):559-569 (2002).
Köhler et al.Nature, 256:495-497 (1975).
Kostelny et al.J. Immunol., 148(5):1547-1553 (1992).
Kyte et al.J. Mol. Biol., 157(1):105-132 (1982).
Kozbor et al.Immunol. Today, 4(3):72-79 (1983).
KozborJ. Immunol., 133(6):3001-3005 (1984).
Lai et al.J. Biol. Chem., 270(40):23254-23257 (1995).
Lonberg et al.Nature, 368:856-859 (1994).
Lonberg et al.Int. Rev. Immunol., 13(1):65-93 (1995).
Marks et al.J. Mol. Biol., 222(3):581-597 (1991).
Marks et al.Biotechnol., 10(7):779-783 (1992).
Milstein et al.Nature, 305:537-540 (1983).
MorrisonNature, 368:812-813 (1994).
Munson et al.Anal. Biochem., 107(1):220-239 (1980).
Needleman et al.J. Mol. Biol., 48(3):443-453 (1970).
NeubergerNat. Biotechnol., 14(7):826 (1996).
O'Dowd et al.Gene, 187(1):75-81 (1997).
Overbergh et al.Cytokine, 11(4):305-312 (1999).
Ozaki et al.Proc. Natl. Acad. Sci. USA, 97(21):11439-11444 (2000).
Page et al.J. Immunol. Methods, 189:129-135 (1996).
Parrish-Novak et al.Nature, 408:57-63 (2000).
PrestaCurr. Op. Sturct. Biol., 2(4):593-596 (1992).
Reiner et al.Annu. Rev. Immunol., 13:151-177 (1995).
Riechmann et al.Nature, 332:323-327 (1988).
Shalaby et al.J. Exp. Med., 175:217-225 (1992).
Shimoda et al.Nature, 380:630-633 (1996).
Suresh et al.Meth. Enzymol., 121:210-228 (1986).
Szabo et al.J. Exp. Med., 185(5):817-824 (1997).
Szabo et al.Cell, 100(6):655-669 (2000).
Takeda et al.Nature, 380:627-630 (1996).
Traunecker et al.EMBO J., 10(12):3655-3659 (1991).
Tutt et al.J. Immunol., 147(1)-60-69 (1991).
Verhoeyen et al.Science, 239:1534-1536 (1988).
Vita et al.J. Biol. Chem., 270(8):3512-3517 (1995).
Vosshenrich et al.Curr. Biol., 11(5):R157-R177 (2001).
WilkinsonThe Scientist, 14(8):25-28 (2000).
Wu et al.J. Immunol., 159:1658-1665 (1997).
Wurster et al.Oncogene, 19(21):2577-2584 (2000).
Yan et al.Science, 290:523-527 (2000).
Zhang et al.J. Biol. Chem., 272(14):9474-9480 (1997).
Bazan “Structural design and molecular evolution of a cytokine receptor superfamily,” Proc. Natl. Acad. Sci. USA 87:6934-38 (1990).
Imler et al. “Identification of three adjacent amino acids of interleukin-2 receptor β chain which control the affinity and the specificity of the interaction with interleukin-2,” EMBO J. 11:2047-53 (1992).
LaRosa et al. “Amino Terminus of the Interleukin-8 Receptor Is a Major Determinant of Receptor Subtype Specificity,” J. Biol. Chem. 267:25402-06 (1992).
Schimmenti et al. “Localization of an essential ligand binding determinant of the human erythropoietin receptor to a domin N-terminal to the WSXWS motif: implications for soluble receptor function,” Exp. Hematol. 23:1341-46 (1995).
Mulhern et al. “The Solution Structure of the Cytokine-binding Domain of the Common β-Chain of the Receptors for Granulocyte-Macrophage Colony-stimulating Factor, Interleukin-3 and Interleukin-5,” J. Mol. Biol. 297:989-1001 (2000).
Woodcock et al. “Three residues in the common β chain of the human GM-CSF, IL-3 and IL-5 receptors are essential for GM-CSF and IL-5 but not IL-3 high affinity binding and interact with Glu21 of GM-CSF,” EMBO J. 13:5176-85 (1994).
Blast 2 Sequences Results comparing GenBank Accession Nos. Q9JHX3 and NP—068570, entitled “Amino Acid Sequence comparison of Mouse and Human IL-21R”, printed Apr. 6, 200
Collins Mary
Grusby Michael J.
Whitters Matthew
Wurster Andrea
Young Deborah
Fitzpatrick ,Cella, Harper & Scinto
Hamud Fozia
O'Hara Eileen
Wyeth
LandOfFree
Methods and compositions for modulating T helper (Th) cell... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for modulating T helper (Th) cell..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for modulating T helper (Th) cell... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2812820